Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview S P 500 And Nasdaq Rise Slightly Dow Slips Modestly 20260403 1 Oak A Stock Analysis Brookfield Oaktree 6.625 Series A Preferred Holds Flat At 100 20260401 What Upcoming Catalysts Matter For Pathward Cash Stock Price At 92.61 Up 0.60 20260408 Will Vir Biotechnology Vir Stock Outperform S P 500 Price At 9.77 Up 2.61 20260409 Is Dick S Dks Stock Priced Correctly Price At 193.76 Up 1.05 20260406 GEF Greif Inc Q3 2025 EPS misses consensus estimates shares dip 15 percent even as quarterly revenue climbs 43 percent Geopark GPRK Stock Bullish Case Technical Weakness 20260418 SelectIncome DNP Stock Technical Trend 076 20260418 PennyMac PFSI revenue surges 55 YoY to 442B despite earnings miss shares rise 2 The PNC Financial Services Group Inc PNC Nuvalent NUVL Stock Credit Spread Near Highs 20260420 ALGM AllegroMicro posts narrow Q1 2026 earnings beat shares climb modestly on positive investor sentiment The opportunity most miss about Nuwellis NUWE Technical Weakness 20260511 What Affects New York NYT Stock Performance Buying Pressure 20260420 How Invitation Homes INVH balances growth with profitability Steady Climb 20260506 Lifeward LFWD Stock Market Trend Overview Lifeward posts big EPS miss spurring steep selloff What would it take for Vivid Seats SEAT to double from here Institutional Demand 20260508 SLXN Silexion Therapeutics posts wider than expected Q4 2025 loss shares dip 094 in todays trading How Albertsons ACI earnings track against industry trends Q1 2026 EPS Tops Views Gold IRA Fees in 2026 How Hidden Markups Could Impact Retirement Portfolio Returns Fermi Surges on Fermi 20 Plan as Investor Optimism Rises Orion ORN Drops 361 Key Support at 1417 20260515 Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Reveals EU Announces Ban on Brazilian Meat Imports from September Escalating Trade Tensions Organigram OGI Flat at 111 Consolidation Continues 20260514 SP 500 Dow Nasdaq Futures Edge Higher After Trump Clears NVDAs H200 Sales to China Cisco in Focus Galectin Therapeutics GALT Q1 2026 Results Miss Estimates EPS 008 vs 006 AmSharedHosp AMS Q1 2026 Results Miss Estimates EPS 009 vs 001 Hayden Panettieres Custody Decision A Personal Narrative with Potential Brand Implications AECOM ACM Q1 2026 Earnings Beat Revenue 1613962200000 EPS 159 Defense Sector in Focus as US Military Jets and Drones Tracked Near Cuba Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends Walmart WMT Gains Hedge Fund Attention Amid Mixed Analyst Outlooks Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Movers Medicares Uncovered Costs Three Basic Expenses That Could Exceed 100000 Annually Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress BHFAN Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Weigh Moving iMage Technologies Inc MITQ Q1 2026 Earnings Narrowing Losses Amid Cinema Technology Transition Guardian Pharmacy Services Q1 2026 Earnings EPS Misses Estimates Amid Modest Market Response Healthcare Services Group Inc HCSG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Uptick Spartacus Acquisition Corp II Unit TMTSU Slips Slightly as SPAC Market Remains in Focus Core AI Holdings CHAI Declines 089 Holds Above Key Support at 105 Gilead Sciences GILD Edges Higher Modestly as Shares Hold Above Key Support Clear Secure Inc YOU Q1 2026 Earnings EPS Beats Estimates by 12 Despite Stock Pullback UL Solutions Inc ULS Q1 2026 Earnings Strong Profit Beat Amid Solid Operational Execution BJs Wholesale Club Q1 2026 Earnings EPS Beat Amid Market Skepticism DocuSign Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Stock Edges Higher TD Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher TDS Q1 2026 Earnings Stunning EPS Beat Driven by Strong Operational Performance TCRT Q4 2023 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue